Phase II Clinical Development of New Drugs

• Κύριοι συγγραφείς: Ting, Naitee (Συγγραφέας), Chen, Ding-Geng (Συγγραφέας), Ho, Shuyen (Συγγραφέας), Cappelleri, Joseph C. (Συγγραφέας)
• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Singapore : Springer Singapore : Imprint: Springer, 2017.
• Σειρά: ICSA Book Series in Statistics,
• Θέματα: Statistics.; Management.; Pharmaceutical technology.; Statistics for Life Sciences, Medicine, Health Sciences.; Pharmaceutical Sciences/Technology.
• Φυσική περιγραφή: XVII, 241 p. 25 illus., 17 illus. in color. online resource.
• ISBN: 9789811041945
• ISSN: 2199-0980

This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.